Cryptococcus neoformans blood stream infection in severe COVID-19 pneumonia.
Thyagarajan RV, Mondy KE, Rose DT.
IDCases. 2021;26:e01274. doi: 10.1016/j.idcr.2021.e01274. Epub 2021 Aug 31.
PMID:34485078
Fungicide-tolerant persister formation during cryptococcal pulmonary infection.
Ke W, Xie Y, Chen Y, Ding H, Ye L, Qiu H, Li H, Zhang L, Chen L, Tian X, Shen Z, Song Z, Fan X, Zong JF, Guo Z, Ma X, Xiao M, Liao G, Liu CH, Yin WB, Dong Z, Yang F, Jiang YY, Perlin DS, Chen Y, Fu YV, Wang L.
Cell Host Microbe. 2024 Feb 14;32(2):276-289.e7. doi: 10.1016/j.chom.2023.12.012. Epub 2024 Jan 11.
PMID:38215741
Bionized Nanoferrite Particles Alter the Course of Experimental Cryptococcus neoformans Pneumonia.
Liporagi Lopes LC, Korangath P, Dos Santos SR Jr, Gabrielson KL, Ivkov R, Casadevall A.
Cryptococcus neoformans endocarditis in an immunocompetentpatient a case report.
McGuire CN, Walter DJ.
BMC Cardiovasc Disord. 2022 Dec 23;22(1):565. doi: 10.1186/s12872-022-02997-9.
PMID:36564757
Co-infection by Cryptococcus neoformans fungaemia and non-tuberculous mycobacteria with Pneumocystis jiroveci pneumonia in a newly diagnosed HIV-infected patient.
Subahi EA, Aljafar MS, Barjas HH, Abdelrazek M, Rasoul FA.
Clin Case Rep. 2021 May 5;9(7):e04191. doi: 10.1002/ccr3.4191. eCollection 2021 Jul.